Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.84
+0.08 (0.82%)
At close: Jun 26, 2026, 4:00 PM EDT
9.88
+0.04 (0.41%)
After-hours: Jun 26, 2026, 7:00 PM EDT
Ocular Therapeutix Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Ocular Therapeutix stock have an average target of 26, with a low estimate of 18 and a high estimate of 31. The average target predicts an increase of 164.23% from the current stock price of 9.84.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ocular Therapeutix stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 7 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Maintains $21 → $23 | Buy | Maintains | $21 → $23 | +133.74% | Jun 25, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $27 | Buy | Reiterates | $27 | +174.39% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $21 → $25 | Buy | Reiterates | $21 → $25 | +154.07% | Jun 22, 2026 |
| Needham | Needham | Buy Maintains $18 | Buy | Maintains | $18 | +82.93% | Jun 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $31 | Buy | Maintains | $31 | +215.04% | Jun 18, 2026 |
Financial Forecast
Revenue This Year
51.91M
from 51.95M
Decreased by -0.08%
Revenue Next Year
120.39M
from 51.91M
Increased by 131.91%
EPS This Year
-1.55
from -1.42
EPS Next Year
-1.54
from -1.55
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 56.3M | 275.0M | |
| Avg | 51.9M | 120.4M | |
| Low | 45.4M | 56.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.4% | 429.8% | |
| Avg | -0.1% | 131.9% | |
| Low | -12.6% | 8.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.27 | -1.30 | |
| Avg | -1.55 | -1.54 | |
| Low | -1.71 | -1.75 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.